Mont-Saint-Guibert, Belgium (December 14, 2021): Tools4Patient‘s Placebell©™ was named one of the most innovative products of 2021 by PM360, a leading trade magazine for marketing decision-makers in the pharmaceutical, biotech, medical device and diagnostics industries. Placebell is an innovative predictive method that addresses this complex challenge of the placebo response in clinical trials. Placebell combines machine learning-based algorithms with individual patient
Topic: T4P News
Tools4Patient’s Placebell©™ technology has been selected as a finalist in the 2019 Clinical Trials Innovation Challenge sponsored by IQVIA, Lundbeck, and LEO Innovation Lab.
Tools4Patient is committed to our mission of developing predictive tools to optimize the evaluation of clinical-stage drugs. Along with our recent launch of Placebell©™ – a predictive algorithm focused on the placebo response – and our recent fundraising to support commercialization of Placebell©™ and further R&D, T4P is entering a new phase as a company.
Placebell©™ technology designed to limit the negative impact of the placebo effect in clinical trials.